These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12967293)

  • 1. Synthesis of a TMC-95A ketomethylene analogue by cyclization via intramolecular Suzuki coupling.
    Kaiser M; Siciliano C; Assfalg-Machleidt I; Groll M; Milbradt AG; Moroder L
    Org Lett; 2003 Sep; 5(19):3435-7. PubMed ID: 12967293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concise formal total synthesis of TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Org Lett; 2003 Jan; 5(2):197-200. PubMed ID: 12529139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: discovery of a new method to generate cis-propenyl amides.
    Lin S; Danishefsky SJ
    Angew Chem Int Ed Engl; 2002 Feb; 41(3):512-5. PubMed ID: 12491396
    [No Abstract]   [Full Text] [Related]  

  • 4. A concise, total synthesis of the TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11949-54. PubMed ID: 15163792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity.
    Yang ZQ; Kwok BH; Lin S; Koldobskiy MA; Crews CM; Danishefsky SJ
    Chembiochem; 2003 Jun; 4(6):508-13. PubMed ID: 12794861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereocontrolled synthesis of the northern part of potent proteasome inhibitor TMC-95A.
    Inoue M; Furuyama H; Sakazaki H; Hirama M
    Org Lett; 2001 Sep; 3(18):2863-5. PubMed ID: 11529776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.
    Kaiser M; Groll M; Renner C; Huber R; Moroder L
    Angew Chem Int Ed Engl; 2002 Mar; 41(5):780-3. PubMed ID: 12491334
    [No Abstract]   [Full Text] [Related]  

  • 8. Total synthesis of TMC-95A and -B via a new reaction leading to Z-enamides. Some preliminary findings as to SAR.
    Lin S; Yang ZQ; Kwok BH; Koldobskiy M; Crews CM; Danishefsky SJ
    J Am Chem Soc; 2004 May; 126(20):6347-55. PubMed ID: 15149232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of the core structure of salicylihalamide A by intramolecular Suzuki reaction.
    Bauer M; Maier ME
    Org Lett; 2002 Jun; 4(13):2205-8. PubMed ID: 12074668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMC-95A, a reversible proteasome inhibitor, induces neurite outgrowth in PC12 cells.
    Inoue M; Zhai H; Sakazaki H; Furuyama H; Fukuyama Y; Hirama M
    Bioorg Med Chem Lett; 2004 Feb; 14(3):663-5. PubMed ID: 14741264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of the cyclopeptide alkaloid abyssenine A. Application of inter- and intramolecular copper-mediated coupling reactions in organic synthesis.
    Toumi M; Couty F; Evano G
    J Org Chem; 2007 Nov; 72(24):9003-9. PubMed ID: 17508763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities.
    Koguchi Y; Kohno J; Nishio M; Takahashi K; Okuda T; Ohnuki T; Komatsubara S
    J Antibiot (Tokyo); 2000 Feb; 53(2):105-9. PubMed ID: 10805568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.
    Groll M; Koguchi Y; Huber R; Kohno J
    J Mol Biol; 2001 Aug; 311(3):543-8. PubMed ID: 11493007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of the squalene synthase inhibitor zaragozic acid C by a carbonyl ylide cycloaddition strategy.
    Nakamura S; Hirata Y; Kurosaki T; Anada M; Kataoka O; Kitagaki S; Hashimoto S
    Angew Chem Int Ed Engl; 2003 Nov; 42(43):5351-5. PubMed ID: 14613174
    [No Abstract]   [Full Text] [Related]  

  • 15. Total synthesis of (+)-peloruside A.
    Jin M; Taylor RE
    Org Lett; 2005 Mar; 7(7):1303-5. PubMed ID: 15787492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of the core structure of apicularen a by transannular cyclization.
    Kühnert SM; Maier ME
    Org Lett; 2002 Feb; 4(4):643-6. PubMed ID: 11843612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093.
    Kohno J; Koguchi Y; Nishio M; Nakao K; Kuroda M; Shimizu R; Ohnuki T; Komatsubara S
    J Org Chem; 2000 Feb; 65(4):990-5. PubMed ID: 10814045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and structural determination of phepropeptins A, B, C, and D, new proteasome inhibitors, produced by Streptomyces sp.
    Sekizawa R; Momose I; Kinoshita N; Naganawa H; Hamada M; Muraoka Y; Iinuma H; Takeuchi T
    J Antibiot (Tokyo); 2001 Nov; 54(11):874-81. PubMed ID: 11827028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending Pummerer reaction chemistry. Application to the oxidative cyclization of tryptophan derivatives.
    Feldman KS; Karatjas AG
    Org Lett; 2004 Aug; 6(17):2849-52. PubMed ID: 15330630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regioselective halogenations and subsequent Suzuki-Miyaura coupling onto bicyclic 2-pyridones.
    Bengtsson C; Almqvist F
    J Org Chem; 2010 Feb; 75(3):972-5. PubMed ID: 20025251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.